Ramy Farid's most recent trade in Vir Biotechnology Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 8,000 | 32,000 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 74,527 | 0 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 16 Apr 2026 | 74,527 | 405,351 (0%) | 0% | 3.1 | 228,798 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.33 per share. | 16 Apr 2026 | 43,000 | 330,824 (0%) | 0% | 12.3 | 530,233 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 16 Apr 2026 | 43,000 | 373,824 (0%) | 0% | 3.1 | 132,010 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 43,000 | 74,527 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 43,000 | 117,527 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.21 per share. | 16 Apr 2026 | 43,000 | 330,824 (0%) | 0% | 12.2 | 524,944 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 16 Apr 2026 | 43,000 | 373,824 (0%) | 0% | 3.1 | 132,010 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.91 per share. | 05 Mar 2026 | 3,661 | 330,824 (0%) | 0% | 12.9 | 47,249 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 56,250 | 278,182 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 48,259 | 340,045 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 13,604 | 291,786 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 02 Mar 2026 | 5,560 | 334,485 (0%) | 0% | 11.9 | 66,151 | Common Stock |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 8,000 | 24,000 (0%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 37,500 | 221,932 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Ramy Farid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 126,000 | 126,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 87,271 | 87,271 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 84,960 | 84,960 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 65,525 | 65,525 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 04 Jan 2023 | 66,886 | 251,318 (0%) | 0% | 1.2 | 80,263 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.28 per share. | 04 Jan 2023 | 66,886 | 184,432 (0%) | 0% | 18.3 | 1,222,669 | Common Stock |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 66,886 | 0 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 215,000 | 215,000 | - | - | Stock Option (right to buy) |